Coronavirus Strategies to Boost Community Coronavirus Strategies to Boost Community


Malaria Vaccine Will Be an Expensive Failure

malaria vaccine

Story at-a-glance -

  • Starting in 2018, GlaxoSmithKline’s (GSK) RTS,S (Mosquirix) malaria vaccine will be given to some children living in Ghana, Kenya and Malawi
  • Research suggests the malaria parasite has wide genetic diversity and the vaccine would need to be 100 percent effective against all the different strains in order to eradicate the disease
  • Separate research found three doses of Mosquirix didn’t prevent malaria infection but rather delayed it until the children were older; the solution was to add a fourth shot to the schedule, but even this may not be enough

By Dr. Mercola

Malaria is a mosquito-borne disease caused by plasmodium parasites. When an infected Anopheles mosquito bites a person, it can spread the disease, leading to flu-like illness that can progress to life-threatening complications if left untreated.

Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access